drugset / Trial / NCT06135844

Hand Sanitizer Use for Herpes Simplex Virus-1

NCT06135844

Phase 0 Unknown 20 enrolled Leciel Bono
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this pilot study is to determine if the use of Purell hand sanitizer alters the duration, level of pain and discomfort during treatment, and the size of the HSV-1 lesion. The duration of an HSV-1 (herpes) lesion is the primary endpoint for this study. Size, pain, and discomfort are the secondary endpoints.

Timeline

Start
2022-04-08
Primary completion
2023-11-30
Completion
2023-11-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Alcohol Other / unclassified 70 % Topical